Marie Obien

MaxWell Monthly Must-Reads (April 2018)

After last month’s successful launch , it is finally time for the April edition of MaxWell Monthly Must-Reads. This month’s blog series will focus on Neuronal Excitability. The topic plays a key role in understanding how neurons encode and transmit information. At MaxWell Biosystems, we aim to develop assays for characterizing neuronal excitability, both in healthy and disease conditions. For this month’s MMM, we include recent studies on different factors that regulate excitability of neurons, such as ion channels, calcium signaling, and…

Read More

MaxWell Monthly Must-Reads (March 2018)

Today, we are launching a new blog series called MaxWell Monthly Must-Reads. Every month, we will feature interesting articles related to neuroscience, stem cell technology, drug discovery, and safety pharmacology. In this edition, we focus on Methods. We value well-designed experimental methods and protocols because they are key to new discoveries and ground-breaking results. Here, we include recent techniques for the generation of functionally active iPSC-derived neurons and brain organoids. We also feature a new single cell manipulation technique called…

Read More

10 Years Venture Kick Ceremony | MaxWell Biosystems is a Global Shaper

MaxWell Biosystems joined the celebration of Venture Kick’s 10-year anniversary last 29 November 2017. Held in Schlieren, the ceremony welcomed 500 guests–all involved in the Swiss innovation, entrepreneurship, and investment community. Venture Kick included a variety of events during the evening, such as a startup exhibition, speeches, guitar concert, and a fashion show. Everyone enjoyed the sumptuous dinner, desserts, and drinks. Global Shapers Venture Kick nominated high-impact startups for each of the ten years since the program started. The Global…

Read More

MaxWell Biosystems wins Venture Kick

MaxWell Biosystems passes the final stage of Venture Kick and wins CHF 100’000. After presenting at the final stage, MaxWell Biosystems convinced the Venture Kick jury and secured CHF 100’000, in addition to CHF 30’000 already granted in previous stages. Venture Kick supports the first steps of the realization of a business idea and awards selected start-ups with up to CHF 130’000 seed money. The final stage serves as the culmination of the year-long journey of MaxWell Biosystems with Venture Kick. The journey started last July…

Read More

MaxWell Biosystems featured in ETH News

MaxWell Biosystems gets more media coverage. ETH Zurich News features the spin-off company MaxWell Biosystems. The article highlights the company’s core technology developed in Hierlemann Lab (D-BSSE) and the motivation to commercialize thanks to the demand of induced pluripotent stem cell boom. Link to English version >> Link to German version >>

Read More
Contact Us






Albisriederstrasse 253
8047 Zurich, Switzerland
+41 44 244 24 24
Schedule a call
info@mxwbio.com
Subscribe to our Newsletter